Trump Administration Imposes New 100% Tariffs on Imported Drugs

The Trump administration announced a 100% tariff on branded drugs from pharmaceutical companies that have not negotiated U.S. drug price reductions. A 20% tariff will apply to those planning to onshore production, increasing to 100% after four years. Companies must complete new domestic plants by January 2029 to qualify for exemptions from the tariffs. Larger drugmakers have 120 days before the tariffs are enacted, while smaller ones have 180 days, which may lead to increased reshoring in the pharmaceutical sector as manufacturers react to these changes.